Wednesday, 16 June 2021

CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.


By BY CARL ZIMMER from NYT Health https://ift.tt/2S4aRhB
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)